Apstatin

Apstatin is a selective inhibitor of aminopeptidase P (APP), with a K|i|of 2.6 μM in rat lung membrane-bound APP. Apstatin is shown to increase Bradykinin-promoted cardioprotection in rats with artificially introduced myocardial infarctions by inhibiting the Bradykinin degradation action of APP. When combined with the angiotensin-converting enzyme inhibitors enalapril , lisinopril , or ramipril , decrease of myocardial infarction size was enhanced. Specification: ≥95% Molecular Formula: C23H33N5O5 Molecular Weight: 459.54 PubChem CID: 447280 Isomeric SMILES: C[C@@H](C(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]2CCCN2C(=O)[C@H]([C@@H](CC3=CC=CC=C3)N)O Related Documents: https://ald-pub-files.oss-cn-shanghai.aliyuncs.com/aladdinsci/pdp/sds/1/A335689-SCI_62830f4a74b3e5dfd3e779a5024aa888.pdf

UPC:

51322202

Condition:

New

Weight:

0.96 Ounces

HazmatClass:

No

Quantity:

1

Unit of Measurement:

EA

WeightUOM:

LB

MPN:

A335689-1mg

CAS:

160470-73-5

Product Size:

1mg

Precautionary Statement Codes:

P264